DRAK2 Antikörper (Internal Region)

Produktnummer ABIN570989

Produktdetails anti-DRAK2 Antikörper

Target: DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))

Bindungsspezifität: Internal Region

Reaktivität: Human

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser DRAK2 Antikörper ist unkonjugiert

Applikation: ELISA, Western Blotting (WB)

Verwendungszweck: DRAK2

Sequenz: HSVRSSEDKT SK

Spezifität: This antiboyd may cross-react with rat STK17B (GeneID: 170904).

Kreuzreaktivität: Hund, Human

Aufreinigung: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Güteklasse: Verified

Immunogen: Peptide with sequence C-HSVRSSEDKTSK, from the internal region of the protein sequence according to NP_004217.1.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Western Blot: Approx 45 kDa band observed in lysates of cell line MOLT4 (calculated MW of 42.3 kDa according to NP_004217.1). Recommended concentration: 1-3 μg/mL.

Peptide ELISA: antibody detection limit dilution 1:32000.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Minimize freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Details zu DRAK2

Target: DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))

Andere Bezeichnung: STK17B (STK17B Produkte)

Hintergrund: STK17B, serine/threonine kinase 17b, DRAK2, death-associated protein kinase-related 2, serine/threonine kinase 17b (apoptosis-inducing)

Gen-ID: 9262

NCBI Accession: NP_004217